Crane NXT (CXT) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
3 Feb, 2026Executive summary
Q3 2025 sales grew 10% year-over-year to $445.1 million, driven by acquisitions, favorable currency, and strong SAT performance.
Adjusted EPS was $1.28, with net income up 7.2% to $50.5 million.
Signed agreements to acquire Antares Vision, expected to close in H1 2026, expanding into life sciences and food & beverage detection and authentication.
International Currency backlog remains at record highs, with orders booked into 2027.
Ongoing softness in CPI short-cycle businesses, but margins maintained through pricing, productivity, and cost actions.
Financial highlights
Q3 2025 net sales: $445.1M (+10.3% YoY); operating profit: $81.9M (+9.2% YoY); net income: $50.5M (+7.2% YoY).
Adjusted EPS was $1.28; adjusted segment operating profit margin increased ~50 bps to 27.6%.
Adjusted EBITDA for Q3 was $122.4 million (27.5% margin).
Free cash flow conversion reached ~115% for the quarter.
Cash provided by operating activities was $92.0 million, with adjusted free cash flow of $85.3 million.
Outlook and guidance
Full-year 2025 sales growth guidance raised to 9–11% (from 6–8%), with adjusted EPS guidance narrowed to $4.00–$4.10.
Adjusted segment operating margin expected at ~25%–26.5%; adjusted free cash flow conversion targeted at 90–110%.
US Currency business expected to see high-single-digit revenue growth in 2026, with new $10 bill production starting mid-2026.
CPI segment sales expected to decline 2–0%, while SAT segment sales are projected to grow 19–21%.
Management expects to recognize 57% of remaining $557M in performance obligations as revenue in 2025, 43% in 2026.
Latest events from Crane NXT
- Targeting ~$2.5B revenue and $600M EBITDA by 2028 through growth, M&A, and innovation.CXT
Investor Day 202625 Feb 2026 - Sales up 11.4%, Adjusted EPS $4.06, 2026 guidance strong, dividend up 6%.CXT
Q4 202512 Feb 2026 - Q2 sales rose 9.1% to $404.4M, with strong SAT growth and robust free cash flow conversion.CXT
Q2 20253 Feb 2026 - Q1 2025 sales up 5.3% to $330.3M; full-year sales growth guidance raised to 6–8%.CXT
Q1 20253 Feb 2026 - Q3 2024 sales up 14.3% to $403.5M, with strong M&A and lower margins year-over-year.CXT
Q3 20243 Feb 2026 - Acquisition-driven growth, tech innovation, and strong cash flow support margin expansion and deleveraging.CXT
24th Annual Diversified Industrials & Services Conference3 Feb 2026 - Sales up 5.2% with OpSec integration, Adjusted EPS $1.06, and record backlog achieved.CXT
Q2 20242 Feb 2026 - £300M acquisition expands authentication portfolio, targeting growth and double-digit ROIC.CXT
M&A Announcement19 Jan 2026 - 2025 sales projected at $1.6B, with Antares Vision acquisition closing in 2026 and strong margins.CXT
CJS Securities 26th Annual "New Ideas for the New Year” Investor Conference14 Jan 2026